Cargando…

Baseline use of hydroxychloroquine or immunosuppressive drugs and the risk of coronavirus disease 2019

BACKGROUND/AIMS: The preventive role of hydroxychloroquine (HCQ) on coronavirus disease 2019 (COVID-19) remains unclear. The aim of this study was to examine the effects of HCQ and other immunosuppressive drugs on the incidence of COVID-19. METHODS: The data were collected from the South Korea Natio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji-Won, Kwak, Sang Gyu, Lee, Hwajeong, Kim, Seong-Kyu, Choe, Jung-Yoon, Park, Sung-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082427/ https://www.ncbi.nlm.nih.gov/pubmed/33706472 http://dx.doi.org/10.3904/kjim.2020.633

Ejemplares similares

Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019
por: Kim, Ji-Won, et al.
Publicado: (2021)

The comparable efficacy of denosumab on bone mineral density in rheumatoid arthritis patients with postmenopausal osteoporosis: A retrospective case-control study
por: Kim, Seong-Kyu, et al.
Publicado: (2023)

Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry
por: Kim, Seong-Kyu, et al.
Publicado: (2020)

Korean rheumatology workforce from 1992 to 2015: current status and future demand
por: Lee, Chan Uk, et al.
Publicado: (2019)

Greater prevalence of seropositivity for anti-cyclic citrullinated peptide antibody in unaffected first-degree relatives in multicase rheumatoid arthritis-affected families
por: Kim, Seong-Kyu, et al.
Publicado: (2013)

Resting energy expenditure is not associated with disease activity in women with rheumatoid arthritis: cross-sectional study
por: Choe, Jung-Yoon, et al.
Publicado: (2014)

Decline of Lung Function in Knee and Spine Osteoarthritis in the Korean Population: Cross-Sectional Analysis of Data from the Korea National Health and Nutrition Examination Survey
por: Kim, Seong-Kyu, et al.
Publicado: (2022)

Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care
por: Park, Sung-Hoon, et al.
Publicado: (2015)

Impact of a pharmaceutical care service for patients with rheumatoid arthritis using a customised mobile device (the PROUD trial): study protocol for a randomised controlled trial
por: Park, Ji-Eun, et al.
Publicado: (2022)

Anti-Sm Antibody, Damage Index, and Corticosteroid Use Are Associated with Cardiac Involvement in Systemic Lupus Erythematosus: Data from a Prospective Registry Study
por: Choe, Jung-Yoon, et al.
Publicado: (2020)

The Effect of Mycophenolate Mofetil on Non-Renal Manifestations in Systemic Lupus Erythematosus: Results from Korean Lupus Network Registry
por: Jung, Ui Hong, et al.
Publicado: (2019)

In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses
por: Kang, Chang Kyung, et al.
Publicado: (2020)

Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment
por: Carbillon, Lionel, et al.
Publicado: (2021)

Immunosuppressants: Coronavirus disease-2019: case report
Publicado: (2020)

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019
por: Sridhar, Arun R., et al.
Publicado: (2020)

Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
por: Sahraei, Zahra, et al.
Publicado: (2020)

Case Series of Patients with Coronavirus Disease 2019 Pneumonia Treated with Hydroxychloroquine
por: Tanaka, Tomohiro, et al.
Publicado: (2023)

Hydroxychloroquine/immunosuppressants: Nosocomial coronavirus disease 2019 (COVID-19), leucopenia and prolonged persistence of COVID-19 following off-label use: case report
Publicado: (2020)

Myth surrounding the FDA disapproval of hydroxychloroquine sulfate and chloroquine phosphate as drugs for coronavirus disease 2019
por: Egbuna, Chukwuebuka, et al.
Publicado: (2022)

Serum Cystatin C is a Potential Endogenous Marker for the Estimation of Renal Function in Male Gout Patients with Renal Impairment
por: Choe, Jung-Yoon, et al.
Publicado: (2010)

Immunosuppressants: Coronavirus-2019 infection: 15 case reports
Publicado: (2020)

Immunosuppressants: Coronavirus disease 2019: 4 case reports
Publicado: (2020)

Corticosteroids/immunosuppressants: Coronavirus disease 2019: case report
Publicado: (2020)

Immunosuppressants: Coronavirus disease of 2019: 3 case reports
Publicado: (2022)

Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease
por: Satlin, Michael J., et al.
Publicado: (2020)

Hydroxychloroquine and Coronavirus Disease 2019: A Systematic Review of a Scientific Failure
por: Rakedzon, Stav, et al.
Publicado: (2020)

Dose Optimization of Hydroxychloroquine for Coronavirus Infection 2019: Do Blood Concentrations Matter?
por: Ippolito, Matthew M, et al.
Publicado: (2020)

The Role of Hydroxychloroquine in Coronavirus Disease 2019. A Versatile Tool at the Service of Humanity
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019
por: Bansal, Pankaj, et al.
Publicado: (2020)

A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance
por: Ahn, Byeong Yun, et al.
Publicado: (2020)

Association of asthma comorbidity with poor prognosis of coronavirus disease 2019
por: Kim, Sae-Hoon, et al.
Publicado: (2021)

Prescription pattern of urate-lowering therapy in Korean gout patients: data from the national health claims database
por: Kim, Ji-Won, et al.
Publicado: (2018)

A Case of Systemic Lupus Erythematosus Presenting as Malignant Hypertension with Hypertensive Retinopathy
por: Choe, Jung-Yoon, et al.
Publicado: (2010)

Risk of coronavirus disease 2019 transmission in an emergency department with multiple open beds
por: Chung, Hyemin, et al.
Publicado: (2021)

Association of Serum Biomarkers With Pulmonary Involvement of Rheumatoid Arthritis Interstitial Lung Disease: From KORAIL Cohort Baseline Data
por: Moon, Jinyoung, et al.
Publicado: (2021)

Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019
por: Sattui, Sebastian E., et al.
Publicado: (2023)

Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring
por: Ramireddy, Archana, et al.
Publicado: (2020)

Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
por: Anupama, B K, et al.
Publicado: (2020)

A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine
por: Mukherjee, Aveek, et al.
Publicado: (2020)

Regarding: “Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019”
por: McCullough, Peter A.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6nm6an0o2o0md8ctcr7olm02ou